论文信息 - Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease - 字舞流文

Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease

C. Cannon | D. McGuire | R. Pratley | S. Dagogo-Jack | R. Frederich | J. Mancuso | N. Cater | D. Bhatt | Joseph M Kim | D. Cherney | Chih-Chin Liu | F. Cosentino